CORONAVIRUS/Medigen gets funds from global foundation for mix-and-match booster trials
12/02/2021 10:51 PM
Taipei, Dec. 2 (CNA) Taiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its COVID-19 vaccine as a potential booster.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Border opening dependent on BA.5 COVID cases: CECC]()
Border opening dependent on BA.5 COVID cases: CECCThe Central Epidemic Command Center (CECC) on Friday said the timeframe for implementing a draft plan submitted by the Tourism Bureau for easing COVID-19 border restrictions ...08/19/2022 07:53 PM![Taiwan gets 1st delivery of Pfizer-BNT vaccines for young children]()
Taiwan gets 1st delivery of Pfizer-BNT vaccines for young childrenYoung children in Taiwan will soon have another option for getting vaccinated against COVID-19 after the country took delivery of some 1.27 million doses of the Pfizer-BioNTech ...08/19/2022 04:59 PM![Taiwan reports 22,819 new COVID-19 cases, 32 deaths]()
Taiwan reports 22,819 new COVID-19 cases, 32 deathsTaiwan on Friday reported 22,819 new cases of COVID-19 and 32 deaths from the disease, according to the Central Epidemic Command Center (CECC).08/19/2022 02:38 PM
Latest
- Society
Taiwan forecast to see temperatures hitting 38 degrees next week
08/20/2022 01:00 PM - Society
Taiwan headline news
08/20/2022 12:05 PM - Politics
Taiwan honors outgoing Palau Ambassador Olkeriil
08/19/2022 10:46 PM - Business
- Society
67 arrested on Southeast Asia human trafficking-related charges: police
08/19/2022 10:17 PM